Optimal effect-site concentration of remifentanil for minimizing cardiovascular changes to nasotracheal intubation during remimazolam anesthesia
Not Applicable
- Conditions
- Not Applicable
- Registration Number
- KCT0007933
- Lead Sponsor
- Pusan National University Dental Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Patients scheduled to undergo oral and maxillofacial surgery
American Society of Anesthesiologist Physical Status (ASA PS) 1,2
Exclusion Criteria
allergic history (remifentanil or any benzodiazepine drugs)
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Dose of remifentanil associated 50% probability for adequate depth of anesthesia for nasotracheal intubation
- Secondary Outcome Measures
Name Time Method Mean arterial pressure, heart rate